Global Pharmaceutical Excipients Market News and Recent Developments

The global pharmaceutical excipients market is evolving rapidly due to increasing investments in pharmaceutical research, advancements in drug formulation technologies, and growing demand for high-performance excipients. Pharmaceutical excipients play a crucial role in modern drug development by enhancing stability, solubility, and bioavailability of active pharmaceutical ingredients (APIs). These developments are driving innovation across excipient manufacturing, regulatory frameworks, and pharmaceutical product development.

According to industry estimates, the global pharmaceutical excipients market was valued at US$ 7,825.38 million in 2021 and is expected to reach US$ 12,245.04 million by 2028, expanding at a CAGR of 6.6% from 2022 to 2028. Increasing adoption of biologics, growing demand for generic drugs, and continuous innovations in drug delivery technologies are supporting the long-term growth of the market.

Market Overview

Pharmaceutical excipients are inactive ingredients used in drug formulations to improve drug delivery, stability, and manufacturing efficiency. They serve multiple functions such as binding, coating, disintegration, lubrication, and stabilization of pharmaceutical products.

The market has experienced significant innovation in recent years as pharmaceutical companies focus on developing complex formulations and biologic therapies. These therapies often require advanced excipients capable of improving drug solubility, protecting sensitive molecules, and enabling controlled drug release.

Recent market developments also highlight a strong focus on sustainable excipient production, multifunctional excipient technologies, and regulatory transparency, all of which are shaping the future of pharmaceutical manufacturing.

Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00003534

Market News and Recent Developments

Product Innovations and New Excipient Launches

Several major pharmaceutical ingredient manufacturers have recently launched new excipient technologies designed to improve drug formulation and delivery. In 2024, BASF introduced a new polymer-based excipient designed to enhance the stability of biologic drugs, which has already been incorporated into numerous drug formulations globally.

Similarly, Evonik Industries launched lipid-based excipients specifically designed for RNA and mRNA drug delivery, supporting the growing development of mRNA-based therapies and vaccines. These excipients help stabilize sensitive RNA molecules and improve drug delivery efficiency.

Another significant development was the launch of plant-derived excipients by Roquette in 2023, reflecting the growing industry trend toward sustainable and bio-based pharmaceutical ingredients. These excipients have seen rapid adoption, particularly in pediatric and patient-friendly drug formulations.

Additionally, Ashland introduced new co-processed excipients designed for pharmaceutical 3D printing technologies, enabling advanced drug manufacturing processes and personalized medicine applications.

Strategic Investments and Capacity Expansion

Leading companies in the pharmaceutical excipients market are also expanding their production capacities to meet growing global demand. For example, BASF expanded its manufacturing capacity in the United States with a new production facility in Texas, increasing output of pharmaceutical-grade excipients used in drug formulations.

Similarly, Clariant expanded its pharmaceutical excipient production facility in Daya Bay, China, adding additional capacity to support growing demand in Asia-Pacific pharmaceutical markets.

In another significant industry move, DFE Pharma expanded its excipient production facility in India, increasing manufacturing capacity by approximately 40% to support the rapidly growing pharmaceutical sector in the region.

These expansions highlight the increasing importance of emerging markets such as India and China in the global pharmaceutical supply chain.

Mergers, Acquisitions, and Strategic Partnerships

Strategic collaborations and acquisitions are also shaping the pharmaceutical excipients industry. One major development was Roquette’s acquisition of IFF Pharma Solutions in 2025, which significantly expanded the company’s excipient portfolio and global manufacturing capabilities.

This acquisition strengthened Roquette’s position in the global excipient market by increasing its presence in cellulose-based and specialty excipients used in oral solid dosage forms and advanced pharmaceutical formulations.

Partnerships between pharmaceutical companies and excipient manufacturers are also becoming more common, allowing companies to develop specialized formulation solutions for complex drug therapies.

Regulatory Developments and Industry Standards

Regulatory developments are playing an increasingly important role in shaping the pharmaceutical excipients market. Governments and regulatory authorities worldwide are strengthening guidelines to improve transparency and ensure the safety of pharmaceutical ingredients.

For instance, India announced new regulations requiring pharmaceutical manufacturers to disclose excipient details through QR codes on medicine packaging starting in March 2026. This initiative aims to enhance patient safety and increase transparency regarding drug formulations.

Additionally, regulatory agencies are working to streamline approval pathways for certain excipient changes, particularly for color additives and formulation components, helping pharmaceutical companies accelerate drug development while maintaining product safety.

Innovation in Advanced Excipients

Recent research and development efforts have also focused on creating excipients that improve drug solubility, bioavailability, and formulation efficiency. Between 2023 and 2025, more than 50 new excipients were introduced globally, with many designed specifically for biologics and complex drug formulations.

In addition, the pharmaceutical industry has increasingly adopted multifunctional excipients that combine multiple formulation functions such as binding, stabilization, and disintegration into a single ingredient. These advanced excipients help reduce manufacturing complexity and improve production efficiency.

The growing adoption of such technologies reflects the pharmaceutical industry's shift toward more efficient and cost-effective drug manufacturing processes.

Key Market Players

Leading companies operating in the global pharmaceutical excipients market include:

· BASF SE

· Evonik Industries AG

· Roquette Frères SA

· Ashland Inc.

· Archer-Daniels-Midland Company

· The Dow Chemical Company

· The Lubrizol Corporation

· Avantor Inc.

· MEGGLE GmbH & Co. KG

· JRS Pharma GmbH & Co. KG

· Univar Solutions Inc.

These companies continue to focus on product innovation, strategic partnerships, and geographic expansion to strengthen their positions in the global pharmaceutical excipients market.

Future Market Outlook

The pharmaceutical excipients market is expected to experience continued growth as pharmaceutical companies increasingly adopt advanced drug delivery systems and develop more complex therapies. Innovations in excipient technology, expanding pharmaceutical manufacturing capacity, and evolving regulatory frameworks will continue to shape the market landscape.

Furthermore, increasing investments in biologics, gene therapies, and personalized medicine are expected to create new opportunities for excipient manufacturers in the coming years.

Related Reports:

Plant Based Vaccines Market

Travel Vaccines Market

Unresectable Hepatocellular Carcinoma Market

About Us

The Insight Partners is a leading global market research and consulting firm specializing in delivering actionable insights across various industries. Our research reports combine extensive primary and secondary research to provide accurate market intelligence, helping businesses make informed strategic decisions. The company provides detailed analysis on emerging technologies, market trends, competitive landscapes, and growth opportunities across sectors including technology, healthcare, manufacturing, and energy.